Alessandro Fatica

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Venues

International journal of molecular sciences

Cancer communications (London, England)

Cellular and molecular life sciences : CMLS

Nature cell biology

Università degli Studi di Roma La Sapienza

Università degli Studi di Roma La Sapienza (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Roma La Sapienza Jan 01 2013

Italy

Associate Professor :: Dept Biology and Biotechnology

Education History

Università degli Studi di Roma La Sapienza Nov 01 1995 - Nov 01 1998

Italy

PHD

Università degli Studi di Roma La Sapienza Oct 01 1990 - Jun 23 1995

Italy

MSC

Publications

Guillermo Fernandez Rodriguez, Marco Tarullo, Alessandro Fatica
N 6 -methyladenosine (m 6 A) RNA modification in chronic myeloid leukemia: unveiling a novel therapeutic target. Cellular and molecular life sciences : CMLS 81 (1) (2024)
Rosa Bordone, Devon Michael Ivy, Rodrigo D'Amico, Martina Barba, Miriam Gaggianesi, Fiorella Di Pastena, Bianca Cesaro, Francesca Bufalieri, Alessio Balzerano, Enrico De Smaele, Giuseppe Giannini, Lucia Di Marcotullio, Alessandro Fatica, Giorgio Stassi, Laura Di Magno, Sonia Coni, Gianluca Canettieri
MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptation. Oncogene (2024)
Srikanth Kodali, Ludovica Proietti, Gemma Valcarcel, Anna V López-Rubio, Patrizia Pessina, Thomas Eder, Junchao Shi, Annie Jen, Núria Lupión-Garcia, Anne C Starner, Mason D Bartels, Yingzhi Cui, Caroline M Sands, Ainoa Planas-Riverola, Alba Martínez-Moreno, Talía Velasco-Hernandez, Laureano Tomás-Daza, Bernhard Alber, Gabriele Manhart, Isabella Maria Mayer, Karoline Kollmann, Alessandro Fatica, Pablo Menendez, Evgenia Shishkova, Rachel E Rau, Biola-Maria Javierre, Joshua J Coon, Qi Chen, Eric L Van Nostrand, José Luis Sardina, Florian Grebien, Bruno Di Stefano
RNA sequestration in P-bodies sustains myeloid leukaemia. Nature cell biology (2024)
Guillermo Fernandez Rodriguez, Marco Tarullo, Alessandro Fatica
N 6 -methyladenosine (m 6 A) RNA modification in chronic myeloid leukemia: unveiling a novel therapeutic target. Cellular and molecular life sciences : CMLS 81 (1) (2024)
Guillermo Fernandez Rodriguez, Marco Tarullo, Alessandro Fatica
N 6 -methyladenosine (m 6 A) RNA modification in chronic myeloid leukemia: unveiling a novel therapeutic target. Cellular and molecular life sciences : CMLS 81 (1) (2024)
Srikanth Kodali, Ludovica Proietti, Gemma Valcarcel, Anna V López-Rubio, Patrizia Pessina, Thomas Eder, Junchao Shi, Annie Jen, Núria Lupión-Garcia, Anne C Starner, Mason D Bartels, Yingzhi Cui, Caroline M Sands, Ainoa Planas-Riverola, Alba Martínez-Moreno, Talía Velasco-Hernandez, Laureano Tomás-Daza, Bernhard Alber, Gabriele Manhart, Isabella Maria Mayer, Karoline Kollmann, Alessandro Fatica, Pablo Menendez, Evgenia Shishkova, Rachel E Rau, Biola-Maria Javierre, Joshua J Coon, Qi Chen, Eric L Van Nostrand, José Luis Sardina, Florian Grebien, Bruno Di Stefano
RNA sequestration in P-bodies sustains myeloid leukaemia. Nature cell biology (2024)
Bianca Cesaro, Marco Tarullo, Alessandro Fatica
Regulation of Gene Expression by m6Am RNA Modification. International journal of molecular sciences 24 (3) (2023)
Bianca Cesaro, Alessia Iaiza, Fabio Piscopo, Marco Tarullo, Eleonora Cesari, Dante Rotili, Antonello Mai, Alberto Diana, Michela Londero, Luca Del Giacco, Riccardo Masetti, Alba Di Leone, Chiara Naro, Silvia Masciarelli, Giulia Fontemaggi, Claudio Sette, Francesco Fazi, Alessandro Fatica
Enhancing sensitivity of triple-negative breast cancer to DNA-damaging therapy through chemical inhibition of the m6A methyltransferase METTL3. Cancer communications (London, England) 44 (2) (2023)
Bianca Cesaro, Alessia Iaiza, Fabio Piscopo, Marco Tarullo, Eleonora Cesari, Dante Rotili, Antonello Mai, Alberto Diana, Michela Londero, Luca Del Giacco, Riccardo Masetti, Alba Di Leone, Chiara Naro, Silvia Masciarelli, Giulia Fontemaggi, Claudio Sette, Francesco Fazi, Alessandro Fatica
Enhancing sensitivity of triple-negative breast cancer to DNA-damaging therapy through chemical inhibition of the m6A methyltransferase METTL3. Cancer communications (London, England) (2023)
Alessandro Fatica
The Emerging Role of RNA in Diseases and Cancers. International journal of molecular sciences 24 (7) (2023)
Bianca Cesaro, Alessia Iaiza, Fabio Piscopo, Marco Tarullo, Eleonora Cesari, Dante Rotili, Antonello Mai, Alberto Diana, Michela Londero, Luca Del Giacco, Riccardo Masetti, Alba Di Leone, Chiara Naro, Silvia Masciarelli, Giulia Fontemaggi, Claudio Sette, Francesco Fazi, Alessandro Fatica
Enhancing sensitivity of triple-negative breast cancer to DNA-damaging therapy through chemical inhibition of the m6A methyltransferase METTL3. Cancer communications (London, England) 44 (2) (2023)
Bianca Cesaro, Alessia Iaiza, Fabio Piscopo, Marco Tarullo, Eleonora Cesari, Dante Rotili, Antonello Mai, Alberto Diana, Michela Londero, Luca Del Giacco, Riccardo Masetti, Alba Di Leone, Chiara Naro, Silvia Masciarelli, Giulia Fontemaggi, Claudio Sette, Francesco Fazi, Alessandro Fatica
Enhancing sensitivity of triple-negative breast cancer to DNA-damaging therapy through chemical inhibition of the m6A methyltransferase METTL3. Cancer communications (London, England) 44 (2) (2023)
Bianca Cesaro, Marco Tarullo, Alessandro Fatica
Regulation of Gene Expression by m6Am RNA Modification. International journal of molecular sciences 24 (3) (2023)
Bianca Cesaro, Marco Tarullo, Alessandro Fatica
Regulation of Gene Expression by m6Am RNA Modification. International journal of molecular sciences 24 (3) (2023)
Bianca Cesaro, Alessia Iaiza, Fabio Piscopo, Marco Tarullo, Eleonora Cesari, Dante Rotili, Antonello Mai, Alberto Diana, Michela Londero, Luca Del Giacco, Riccardo Masetti, Alba Di Leone, Chiara Naro, Silvia Masciarelli, Giulia Fontemaggi, Claudio Sette, Francesco Fazi, Alessandro Fatica
Enhancing sensitivity of triple-negative breast cancer to DNA-damaging therapy through chemical inhibition of the m6A methyltransferase METTL3. Cancer communications (London, England) 44 (2) (2023)
Guillermo Fernandez Rodriguez, Bianca Cesaro, Alessandro Fatica
Multiple Roles of m6A RNA Modification in Translational Regulation in Cancer. International journal of molecular sciences 23 (16) (2022)
Chiara Turco, Gabriella Esposito, Alessia Iaiza, Frauke Goeman, Anna Benedetti, Enzo Gallo, Theodora Daralioti, Letizia Perracchio, Andrea Sacconi, Patrizia Pasanisi, Paola Muti, Claudio Pulito, Sabrina Strano, Zaira Ianniello, Alessandro Fatica, Mattia Forcato, Francesco Fazi, Giovanni Blandino, Giulia Fontemaggi
MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer. Communications biology 5 (1) (2022)
Francesco Fazi, Alessandro Fatica
Regulation of Ribosome Function by RNA Modifications in Hematopoietic Development and Leukemia: It Is Not Only a Matter of m6A. International journal of molecular sciences 22 (9) (2021)
Zaira Ianniello, Melissa Sorci, Lavinia Ceci Ginistrelli, Alessia Iaiza, Marcella Marchioni, Claudia Tito, Ernestina Capuano, Silvia Masciarelli, Tiziana Ottone, Cristina Attrotto, Manuela Rizzo, Luca Franceschini, Stefano de Pretis, Maria Teresa Voso, Mattia Pelizzola, Francesco Fazi, Alessandro Fatica
New insight into the catalytic -dependent and -independent roles of METTL3 in sustaining aberrant translation in chronic myeloid leukemia. Cell death & disease 12 (10) (2021)
Mariangela Morlando, Alessandro Fatica
Alteration of Epigenetic Regulation by Long Noncoding RNAs in Cancer. International journal of molecular sciences 19 (2) (2018)
Zaira Ianniello, Alessandro Fatica
N6-Methyladenosine Role in Acute Myeloid Leukaemia. International journal of molecular sciences 19 (8) (2018)

Alessandro Fatica.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alessandro Fatica